Reported Sep 26, 2018 · Terminated

URO-3 Triple Stain (CD44 + p53) with CK20, Catalog #: PM370TSAA, Package Type: Bag, which contains components: a) CD44…

Biocare Medical, LLC

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: Biocare Medical, LLC · 60 Berry Dr · Pacheco, CA · 94553-5601

Is this the product you have?

    • URO-3 Triple Stain (CD44 + p53) with CK20
    • Catalog #: PM370TSAA
  • Package TypeBag
  • which contains components
    • a) CD44 + p53
    • Catalog #: PM373DSAA
  • Package Type
    • Bottle
    • and b) CK20
    • Catalog #: PM062AA
  • Package TypeBottle
  • Product UsageURO-3 Triple Stain (CD44 + p53) with CK20 is a cocktail of mouse monoclonal and rabbit monoclonal antibodies that is intended for laboratory use in the qualitative identification of CD44, p53 and CK20 proteins by immunohistochemistry (IHC) in formalin-fixed paraffin-embedded (FFPE) human tissues, primarily for bladder cancer characterization. The clinical interpretation of any staining or its absence should be complemented by morphological studies using proper controls and should be evaluated within the context of the patient s clinical history and other diagnostic tests by a qualified pathologist. The URO-3 Triple Stain is an adjunct immunohistochemistry test to assist a qualified pathologist in differentiating urothelial reactive atypia from CIS (carcinoma in situ) in suspected bladder lesions. The URO-3 staining pattern will be used as supporting data along with morphological and patient history context for the qualified pathologist to render a diagnosis
Lot codes and dates
  • Lot060617
  • Expiration2019/05
  • with a) Lot
    • 060117
    • and b) 053117
Amount recalled
11

Where it was sold

Why it was recalled

Immunohistochemistry device kits found to display incorrect staining pattern due to mislabeling of two components.

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new Biocare Medical, LLC recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (openFDA)

Read the FDA (openFDA device enforcement) notice

Notice updated Apr 22, 2020 · Data as of Sep 19, 5:20 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.